Clinical Trial Update: A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating berberine hydrochloride for prevention of colorectal adenomas in patients with previous colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenomas
• Colorectal Cancer

Drugs mentioned

• Berberine hydrochloride (berberine hydrochloride)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Colorectal Adenomas | Phase 2, Phase 3 | Status: COMPLETED